PMID- 21851269 OWN - NLM STAT- MEDLINE DCOM- 20120326 LR - 20211020 IS - 1937-335X (Electronic) IS - 1937-3341 (Print) IS - 1937-3341 (Linking) VI - 17 IP - 23-24 DP - 2011 Dec TI - Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering. PG - 2943-54 LID - 10.1089/ten.tea.2010.0674 [doi] AB - Human umbilical cord mesenchymal stem cells (hUCMSCs) avoid the invasive procedure required to harvest bone marrow MSCs. The addition of collagen fibers into self-setting calcium phosphate cement (CPC) may increase the scaffold strength, and enhance cell attachment and differentiation. The objectives of this study were to develop a novel class of collagen-CPC composite scaffolds, and to investigate hUCMSC attachment, proliferation, and osteogenic differentiation on collagen-CPC scaffolds for the first time. Collagen fibers in CPC improved the load-bearing capability. Flow cytometry showed that the hUCMSCs expressed cell surface markers characteristic of MSCs, and were negative for hematopoietic and endothelial cell markers. hUCMSCs proliferated rapidly in all CPC composite scaffolds, with cell number increasing by sevenfold in 8 days. Cellular function was enhanced with collagen fibers in CPC scaffolds. Cell density increased from (645+/-60) cells/mm(2) on CPC with 0% collagen, to (1056+/-65) cells/mm(2) on CPC with 8% collagen (p<0.05). The actin stress fibers inside the hUCMSCs were stained, and the fluorescence intensity was doubled when the collagen in CPC was increased by 0% to 8%. RT-PCR showed that hUCMSCs on CPC with collagen had higher osteogenic expression than those on CPC without collagen. Alizarin Red S staining revealed a great increase in mineralization by hUCMSCs on CPC with collagen than that without collagen. In conclusion, hUCMSCs showed excellent proliferation, differentiation, and synthesis of bone minerals in collagen-CPC composite scaffolds for the first time. The novel hUCMSC-seeded collagen-CPC construct with superior cell function and load-bearing capability is promising to enhance bone regeneration in a wide range of orthopedic and craniofacial applications. FAU - Thein-Han, WahWah AU - Thein-Han W AD - Biomaterials and Tissue Engineering Division, Department of Endodontics, Prosthodontics and Operative Dentistry, University of Maryland Dental School, Baltimore, MD 21201, USA. FAU - Xu, Hockin H K AU - Xu HH LA - eng GR - R01 DE014190/DE/NIDCR NIH HHS/United States GR - R01 DE14190/DE/NIDCR NIH HHS/United States GR - R01 DE17974/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110818 PL - United States TA - Tissue Eng Part A JT - Tissue engineering. Part A JID - 101466659 RN - 0 (Actins) RN - 0 (Anthraquinones) RN - 0 (Bone Cements) RN - 0 (Calcium Phosphates) RN - 60MEW57T9G (alizarin) RN - 9007-34-5 (Collagen) SB - IM MH - Actins/metabolism MH - Animals MH - Anthraquinones/metabolism MH - Bone Cements/*pharmacology MH - Bone and Bones/*drug effects MH - Calcium Phosphates/*pharmacology MH - Cattle MH - Cell Adhesion/drug effects MH - Cell Count MH - Cell Differentiation/drug effects/genetics MH - Cell Survival/drug effects MH - Collagen/*pharmacology MH - Fluorescence MH - Humans MH - Immunophenotyping MH - Mechanical Phenomena/drug effects MH - Mesenchymal Stem Cells/*cytology/drug effects/metabolism MH - Microspheres MH - Osteogenesis/drug effects/genetics MH - Stress Fibers/metabolism MH - Tissue Engineering/*methods MH - Tissue Scaffolds/*chemistry MH - Umbilical Cord/cytology PMC - PMC3226062 EDAT- 2011/08/20 06:00 MHDA- 2012/03/27 06:00 PMCR- 2012/12/01 CRDT- 2011/08/20 06:00 PHST- 2011/08/20 06:00 [entrez] PHST- 2011/08/20 06:00 [pubmed] PHST- 2012/03/27 06:00 [medline] PHST- 2012/12/01 00:00 [pmc-release] AID - 10.1089/ten.tea.2010.0674 [pii] AID - 10.1089/ten.tea.2010.0674 [doi] PST - ppublish SO - Tissue Eng Part A. 2011 Dec;17(23-24):2943-54. doi: 10.1089/ten.tea.2010.0674. Epub 2011 Aug 18.